Redesign of P and T Committee functions and processes

A model

Carol L. Croft, Vicki S. Crane

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rapid increases in drug expenditures and staff dissatisfaction with the P and T Committee prompted Parkland Health and Hospital System to undertake a redesign of its P and T Committee functions and processes in 1996. Along with ensuring greater front-line physician representation on the P and T Committee, the redesign expanded the committee's focus from cost containment to appropriate drug utilization to optimize outcomes and decrease overall treatment costs. This article discusses the four major components of the redesign - (1) streamlining P and T Committee-medical staff interaction, (2) instituting systems improvements to ensure quality in medication use, (3) broadening the scope of drug use evaluations, and (4) developing more balanced approaches to drug cost containment. The rationale behind these components are explained, and examples of specific initiatives and results to date are provided.

Original languageEnglish (US)
Pages (from-to)1105-1122
Number of pages18
JournalFormulary
Volume33
Issue number11
StatePublished - 1998

Fingerprint

Cost Control
Drug Utilization
Drug Evaluation
Drug Costs
Medical Staff
Health Expenditures
Health Care Costs
Physicians
Health
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Redesign of P and T Committee functions and processes : A model. / Croft, Carol L.; Crane, Vicki S.

In: Formulary, Vol. 33, No. 11, 1998, p. 1105-1122.

Research output: Contribution to journalArticle

Croft, CL & Crane, VS 1998, 'Redesign of P and T Committee functions and processes: A model', Formulary, vol. 33, no. 11, pp. 1105-1122.
Croft, Carol L. ; Crane, Vicki S. / Redesign of P and T Committee functions and processes : A model. In: Formulary. 1998 ; Vol. 33, No. 11. pp. 1105-1122.
@article{39ff8be6057a4ddf9ce9588d2d3ac2c2,
title = "Redesign of P and T Committee functions and processes: A model",
abstract = "Rapid increases in drug expenditures and staff dissatisfaction with the P and T Committee prompted Parkland Health and Hospital System to undertake a redesign of its P and T Committee functions and processes in 1996. Along with ensuring greater front-line physician representation on the P and T Committee, the redesign expanded the committee's focus from cost containment to appropriate drug utilization to optimize outcomes and decrease overall treatment costs. This article discusses the four major components of the redesign - (1) streamlining P and T Committee-medical staff interaction, (2) instituting systems improvements to ensure quality in medication use, (3) broadening the scope of drug use evaluations, and (4) developing more balanced approaches to drug cost containment. The rationale behind these components are explained, and examples of specific initiatives and results to date are provided.",
author = "Croft, {Carol L.} and Crane, {Vicki S.}",
year = "1998",
language = "English (US)",
volume = "33",
pages = "1105--1122",
journal = "Formulary",
issn = "0098-6909",
publisher = "Advanstar Communications",
number = "11",

}

TY - JOUR

T1 - Redesign of P and T Committee functions and processes

T2 - A model

AU - Croft, Carol L.

AU - Crane, Vicki S.

PY - 1998

Y1 - 1998

N2 - Rapid increases in drug expenditures and staff dissatisfaction with the P and T Committee prompted Parkland Health and Hospital System to undertake a redesign of its P and T Committee functions and processes in 1996. Along with ensuring greater front-line physician representation on the P and T Committee, the redesign expanded the committee's focus from cost containment to appropriate drug utilization to optimize outcomes and decrease overall treatment costs. This article discusses the four major components of the redesign - (1) streamlining P and T Committee-medical staff interaction, (2) instituting systems improvements to ensure quality in medication use, (3) broadening the scope of drug use evaluations, and (4) developing more balanced approaches to drug cost containment. The rationale behind these components are explained, and examples of specific initiatives and results to date are provided.

AB - Rapid increases in drug expenditures and staff dissatisfaction with the P and T Committee prompted Parkland Health and Hospital System to undertake a redesign of its P and T Committee functions and processes in 1996. Along with ensuring greater front-line physician representation on the P and T Committee, the redesign expanded the committee's focus from cost containment to appropriate drug utilization to optimize outcomes and decrease overall treatment costs. This article discusses the four major components of the redesign - (1) streamlining P and T Committee-medical staff interaction, (2) instituting systems improvements to ensure quality in medication use, (3) broadening the scope of drug use evaluations, and (4) developing more balanced approaches to drug cost containment. The rationale behind these components are explained, and examples of specific initiatives and results to date are provided.

UR - http://www.scopus.com/inward/record.url?scp=0032435551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032435551&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 1105

EP - 1122

JO - Formulary

JF - Formulary

SN - 0098-6909

IS - 11

ER -